Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1259)
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
6,552
Price
$8.94
Total Value
$58.57K
Shares Held After
16,817,573
% of Holdings
0.0%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
6,400
Price
$76.05
Total Value
$486.73K
Shares Held After
226,064
% of Holdings
2.8%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
16,896
Price
$74.95
Total Value
$1.27M
Shares Held After
232,464
% of Holdings
6.8%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
9,704
Price
$74.27
Total Value
$720.74K
Shares Held After
249,360
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$542.80
Total Value
$21.71K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$541.10
Total Value
$194.80K
Shares Held After
40,553
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$539.60
Total Value
$172.67K
Shares Held After
40,913
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
409
Price
$538.60
Total Value
$220.29K
Shares Held After
41,233
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
665
Price
$537.66
Total Value
$357.55K
Shares Held After
41,642
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,223
Price
$536.52
Total Value
$1.19M
Shares Held After
42,307
% of Holdings
5.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,191
Price
$535.47
Total Value
$1.17M
Shares Held After
44,530
% of Holdings
4.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,272
Price
$534.63
Total Value
$1.21M
Shares Held After
46,721
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,020
Price
$533.70
Total Value
$544.38K
Shares Held After
48,993
% of Holdings
2.0%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,490
Price
$82.02
Total Value
$614.33K
Shares Held After
377,820
% of Holdings
1.9%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
10
Price
$82.02
Total Value
$820.20
Shares Held After
377,820
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
48,211
Price
$2.42
Total Value
$116.67K
Shares Held After
2,790,103
% of Holdings
1.7%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
300
Price
$85.63
Total Value
$25.69K
Shares Held After
15,312
% of Holdings
1.9%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
5,656
Price
$84.90
Total Value
$480.20K
Shares Held After
15,612
% of Holdings
26.6%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
3,743
Price
$84.26
Total Value
$315.37K
Shares Held After
21,268
% of Holdings
15.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
300
Price
$83.07
Total Value
$24.92K
Shares Held After
25,011
% of Holdings
1.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
18
Price
$303.03
Total Value
$5.45K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
136
Price
$302.19
Total Value
$41.10K
Shares Held After
18
% of Holdings
88.3%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
150
Price
$301.18
Total Value
$45.18K
Shares Held After
154
% of Holdings
49.3%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
370
Price
$300.12
Total Value
$111.04K
Shares Held After
304
% of Holdings
54.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
5,143
Price
$298.94
Total Value
$1.54M
Shares Held After
674
% of Holdings
88.4%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,074
Price
$298.35
Total Value
$917.13K
Shares Held After
5,817
% of Holdings
34.6%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,314
Price
$297.23
Total Value
$390.56K
Shares Held After
8,891
% of Holdings
12.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,493
Price
$296.07
Total Value
$442.03K
Shares Held After
10,205
% of Holdings
12.8%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
15,102
Price
$8.97
Total Value
$135.46K
Shares Held After
16,811,021
% of Holdings
0.1%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
442
Price
$12.84
Total Value
$5.67K
Shares Held After
884,152
% of Holdings
0.0%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
15,283
Price
$12.01
Total Value
$183.56K
Shares Held After
884,594
% of Holdings
1.7%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
24,165
Price
$75.16
Total Value
$1.82M
Shares Held After
0
% of Holdings
100.0%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
28
Price
$29.68
Total Value
$831.04
Shares Held After
362,152
% of Holdings
0.0%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
9,972
Price
$28.42
Total Value
$283.37K
Shares Held After
362,180
% of Holdings
2.7%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
43,367
Price
$2.43
Total Value
$105.38K
Shares Held After
2,741,892
% of Holdings
1.6%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
268
Price
$29.40
Total Value
$7.88K
Shares Held After
822,240
% of Holdings
0.0%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
19,799
Price
$28.61
Total Value
$566.41K
Shares Held After
822,508
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$553.47
Total Value
$44.28K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$548.44
Total Value
$219.38K
Shares Held After
40,593
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,578
Price
$547.17
Total Value
$863.44K
Shares Held After
40,993
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,438
Price
$546.42
Total Value
$785.75K
Shares Held After
42,571
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,524
Price
$545.54
Total Value
$831.41K
Shares Held After
44,009
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
364
Price
$544.54
Total Value
$198.21K
Shares Held After
45,533
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
676
Price
$543.34
Total Value
$367.30K
Shares Held After
45,897
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,870
Price
$542.49
Total Value
$1.01M
Shares Held After
46,573
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
970
Price
$541.47
Total Value
$525.23K
Shares Held After
48,443
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$540.37
Total Value
$324.22K
Shares Held After
49,413
% of Holdings
1.2%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
15,000
Price
$17.61
Total Value
$264.12K
Shares Held After
179,090
% of Holdings
7.7%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
1,700
Price
$2.70
Total Value
$4.59K
Shares Held After
385,075
% of Holdings
0.4%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$3.04
Total Value
$15.20K
Shares Held After
635,812
% of Holdings
0.8%
Showing 201–250 of 1259 transactions (page 5 of 26)